Skip to main content
RNA logo

RNA · Atrium Therapeutics, Inc. · Short Interest

Track RNA — free
$10.36 +0.01 (+0.10%) At close · Sep 11
Market Cap
$177.21M
Shares
17.11M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

RNA Latest Reported Short Interest

FINRA reported 3,351,526 RNA shares sold short as of the August 31, 2026 settlement date, a decrease of 129,323 shares. Days to cover was 19.79 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

RNA Short Interest Forecast

Equibles' model estimates 3,338,174 shares sold short for the September 15, 2026 settlement, -0.4% versus the latest reported position, with a likely range of 2,896,921 to 3,743,111 shares. This model prediction uses FINRA data through September 11, 2026; FINRA's official release is expected September 24, 2026.

Model estimate

Expected Sep 15 short interest

as of Sep 11 Medium confidence 64% chance it falls
3,338,174 -0.4% vs reported
Likely range 2,896,921 to 3,743,111 The latest estimate appears in the chart below. Official release expected Sep 24. Methodology
Short Squeeze Score
65/100
Short interest 19.6% of shares — P98 Days to cover 19.8 — P96 Price vs VWAP -16.6% — P16 Short-volume trend -7.1% — P24 Short interest change -3.7% — P31 Worst FTD 0.03% of shares — P68

Positioning score 64.6 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-08-31). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

The selected options expiration is incomplete or temporarily unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-09-13 14:30 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-09-30 Scheduled
FINRA publishes Oct 9
2026-09-15 Scheduled
FINRA publishes Sep 24
2026-08-31 3,351,526 3,480,849 -129,323 19.79
2026-08-14 3,480,849 3,514,133 -33,284 27.46
2026-07-31 3,514,133 3,591,224 -77,091 28.39
2026-07-15 3,591,224 3,656,821 -65,597 17.71
2026-06-30 3,656,821 3,610,418 +46,403 12.52
2026-06-15 3,610,418 3,653,605 -43,187 20.31
2026-05-29 3,653,605 3,732,204 -78,599 15.83
2026-05-15 3,732,204 3,425,955 +306,249 21.18
2026-04-30 3,425,955 3,016,880 +409,075 8.71
2026-04-15 3,016,880 1,913,700 +1,103,180 6.00
2026-03-31 1,913,700 1,184,615 +729,085 2.90
2026-03-13 1,184,615 432,798 +751,817 1.00
2026-02-27 432,798 0 +432,798 1.00
2026-02-13 10,156,722 8,745,197 +1,411,525 3.56
2026-01-30 8,745,197 8,406,349 +338,848 6.35
2026-01-15 8,406,349 8,791,796 -385,447 4.20
2025-12-31 8,791,796 9,740,063 -948,267 4.61
2025-12-15 9,740,063 8,865,578 +874,485 4.12
2025-11-28 8,865,578 10,321,719 -1,456,141 3.31
2025-11-14 10,321,719 10,497,758 -176,039 2.03
2025-10-31 10,497,758 20,028,193 -9,530,435 1.00
2025-10-15 20,028,193 20,751,004 -722,811 13.50
2025-09-30 20,751,004 22,242,546 -1,491,542 7.32
2025-09-15 22,242,546 17,571,891 +4,670,655 4.21

Full FINRA short interest reporting calendar

Showing 1–24 of 24 settlements
Key facts CIK 2093101 CUSIP 04965N104 13F (30d) 64 filings 64 filers Visit website Investor relations